Perseus Proteomics, Inc. (4882) Stock Statistics & Valuation Metrics

Perseus Proteomics, Inc. has a market cap or net worth of ¥2.75B. The enterprise value is ¥608.57M.

Perseus Proteomics, Inc. has 18,429,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Perseus Proteomics, Inc.’s return on equity (ROE) is -0.59 and return on invested capital (ROIC) is -47.81%.

The current PE Ratio of Perseus Proteomics, Inc. is ―. Perseus Proteomics, Inc.’s PEG ratio is 0.19.

In the last 12 months, Perseus Proteomics, Inc. had revenue of 135.51M and earned -718.11M in profits. Earnings per share was -48.17.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Perseus Proteomics, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Perseus Proteomics, Inc. upcoming earnings date is Aug 13, 2026, TBA (Confirmed).

Perseus Proteomics, Inc. as a current ratio of 24.58, with Debt / Equity ratio of 0.00%

In the past 12 months, Perseus Proteomics, Inc. has paid 1.93M in taxes.

Perseus Proteomics, Inc. EV to EBITDA ratio is -2.46, with an EV/FCF ratio of -2.66.

Perseus Proteomics, Inc. has ¥1.52B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of ¥1.52B billion.

Gross margin is 85.73%, with operating margin of -549.75%, and net profit margin of -529.94%.

The average price target for Perseus Proteomics, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―